Background Image
Previous Page  9 / 102 Next Page
Information
Show Menu
Previous Page 9 / 102 Next Page
Page Background

F

elipe

-S

ilva

A

et

al

.

190

R

ev

A

ssoc

M

ed

B

ras

2014; 60(3):190-191

Accreditation

Update on polycystic kidney disease (hereditary): genetic

diagnosis and counseling

A

tualização

em

glaucoma

de

ângulo

fechado

:

diagnóstico

W

anderley

M. B

ernardo

, M

artin

R. W

hittle

e

R

icardo

S

imões

http://dx.doi.org/10.1590/1806-9282.60.03.003

1. In prenatal and neonatal context, is ultrasonogra-

phy sufficient to confirm the clinical diagnosis of

autosomal recessive polycystic kidney disease (AR-

PKD)?

a.

Ultrasound examination is not the 1

st

investigation

to be applied to fetuses and neonates with suspected

disease.

b.

Yes, without the need for other tests.

c.

Renal ultrasound abnormalities are detectable from

32 weeks of gestation.

d.

Renal ultrasound abnormalities are detectable from

the 13th week of pregnancy when the diagnosis was

previously established in an affected sibling.

2. In the context of an adult, if the result of the ul-

trasound examination is inconclusive, does the

molecular test allow reaching a definitive conclu-

sion?

a.

Molecular tests may be indirect, such as PKHD1 gene

sequencing, or indirect, using linkage analysis.

b.

Molecular tests can be direct, such as linkage analysis.

c.

The type and position of mutations in the PKHD1

gene provide information about the prognosis of the

disease.

d.

Direct molecular genetic testing can detect all muta-

tions causing ARPKD.

3. Does ultrasound examination allow confirming

the clinical diagnosis of autosomal dominant

polycystic kidney disease (ADPKD)?

a.

In patients aged 15 to 29 years with 3 or more unila-

teral or bilateral cysts, the sensitivity is 69.5% and spe-

cificity is 100%.

b.

In patients aged 40 to 59 years with 2 or more unila-

teral or bilateral cysts, the sensitivity is 70% and spe-

cificity is 78%.

c.

Patients aged over 60 years with 4 or more cysts in

each kidney, sensitivity is 1% and specificity is 1%.

d.

Investigation using ultrasound is not recommended

as a first choice.

4. What are the advantages and disadvantages of indi-

rect

versus

direct approaches inmolecular testing for

ADPKD?

a.

Genetic linkage analysis (using polymorphic markers

within and / or near the genes that define haplotypes)

complements the indirect tests.

b.

Haplotype analysis is quick, simple and inexpensive.

c.

Indirect studies can be made in a single patient, but

are costly, time consuming and expensive and do not

always provide definitive information.

d.

Gene sequencing is the most direct.

5. What is the role of molecular testing for genetic

counseling of a couple or family that carries

ADPKD?

a.

Molecular tests are the only investigation that can pro-

vide predictive information about ADPKD in indivi-

duals before clinical signs and symptoms develop.

b.

The type of mutations in the genes provides Infor-

mation about the disease’s diagnosis.

c.

Gene rearrangements comprise around 40% of the

molecular lesions.

d.

In all families the disease develops similarly among

affected siblings.

A

nswers

to

clinical

scenario

:

update

on

vaccination

for

the

prevention

of

infectious

respiratory

disease

in

ddults

[

published

in

RAMB 2014; 60(2)]

1. Is there benefit in vaccine combination for the

prevention of infectious respiratory diseases in

adults?

Both the anti-influenza and pneumococcal vaccines

reduce hospitalizations. (alternative B)

2. Are there any differences between pneumococcal

polysaccharide vaccines (VPPS-23) and conjuga-

te vaccines?

The pneumococcal vaccine is not recommended for

pregnant women. (alternative C)